SCHEMBL24112178

SCHEMBL24112178

Clc1ccc2c(c1)CC(Nc1ncc(Br)cn1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
IDH1 O75874 1/20 0.39
GRIA2 P42262 1/20 0.38
ENPP2 Q13822 1/20 0.38
HDAC8 Q9BY41 5/20 0.36
HDAC6 Q9UBN7 3/20 0.36
GRM2 Q14416 1/20 0.36
GRM3 Q14832 1/20 0.36
PRMT5 O14744 1/20 0.36
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
MCHR1 Q99705 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
GBA1 P04062 1/20 0.34
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24112177 1.00 MAPK1 (0.39) MAPK1IDH1GRIA2ENPP2HDAC8
SCHEMBL30724675 0.83 HDAC8 (0.47) MAPK1IDH1GRIA2ENPP2HDAC8
SCHEMBL28925378 0.82 GRIA2 (0.38) MAPK1IDH1GRIA2ENPP2HDAC8
SCHEMBL22057917 0.81 ENPP2 (0.48) ENPP2GBA1
SCHEMBL29771574 0.81 ENPP2 (0.48) ENPP2GBA1
SCHEMBL22092783 0.81 ENPP2 (0.41) IDH1ENPP2HDAC8HDAC6
SCHEMBL22092784 0.81 ENPP2 (0.41) IDH1ENPP2HDAC8HDAC6
SCHEMBL22092898 0.81 IDH1 (0.39) MAPK1IDH1GRIA2ENPP2HDAC8
SCHEMBL28647967 0.81 IDH1 (0.39) MAPK1IDH1GRIA2ENPP2HDAC8
SCHEMBL23519728 0.80 HDAC8 (0.38) MAPK1ENPP2HDAC8HDAC6GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112172-A1 SUBSTITUED AMINO-PYRIMIDINES HOFFMANN-LA ROCHE INC. (US) 2023-04-13 US disclosed
US-20230112172-A1 SUBSTITUED AMINO-PYRIMIDINES HOFFMANN-LA ROCHE INC. (US) 2023-04-13 US disclosed
CN-115551844-A Substituted amino-pyrimidines 豪夫迈·罗氏有限公司 2022-12-30 CN disclosed
WO-2021249892-A1 SUBSTITUTED AMINO-PYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230112172-A1 SUBSTITUED AMINO-PYRIMIDINES TYMS, TYMP, HPRT1 MAPK1 2984/4885IDH1 406/4885GRIA2 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.